venlafaxine hydrochloride has been researched along with topiramate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A | 1 |
Alexandre, J; Durand, JP; Goldwasser, F; Guillevin, L | 1 |
Peres, MF; Vieira, DS | 1 |
Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I | 1 |
Barceló, B; Castanyer, B; Puiguriguer, J; Yates, C | 1 |
Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS | 1 |
Cooper-Kazaz, R | 1 |
Gui, J; Maguen, S; Schnurr, PP; Shiner, B; Watts, BV; Westgate, CL; Young-Xu, Y | 1 |
Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
9 other study(ies) available for venlafaxine hydrochloride and topiramate
Article | Year |
---|---|
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride | 2001 |
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclohexanols; Female; Fructose; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nervous System Diseases; Recovery of Function; Topiramate; Venlafaxine Hydrochloride | 2005 |
Tension-type headache with aura.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Bromazepam; Cyclohexanols; Fructose; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Topiramate; Venlafaxine Hydrochloride; Vision Disorders | 2006 |
Topiramate use in alprazolam addiction.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Delayed seizures after topiramate, venlafaxine and quetiapine overdose].
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Overdose; Fatal Outcome; Female; Fructose; Humans; Quetiapine Fumarate; Seizures; Time Factors; Topiramate; Venlafaxine Hydrochloride; Young Adult | 2010 |
Teaching case: menopausal migraine.
Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride | 2010 |
Treatment of night eating syndrome with topiramate: dawn of a new day.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Drug Therapy, Combination; Feeding and Eating Disorders; Feeding Behavior; Female; Fructose; Humans; Middle Aged; Sleep Initiation and Maintenance Disorders; Topiramate; Venlafaxine Hydrochloride | 2012 |
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
Topics: Adult; Anticonvulsants; Female; Fluoxetine; Humans; Male; Medical Records; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2018 |
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |